ASDAS-CRP and ASDAS-ESR cut-offs for disease activity states in axial spondyloarthritis - Are they interchangeable?
CONCLUSION: We estimated the optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-off values. However, applying the estimated cut-offs did not increase the level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states to a relevant degree. Our findings did not provide evidence to reject the established cut-off values for ASDAS-ESR.PMID:38621792 | DOI:10.3899/jrheum.2023-1217 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Stylianos Georgiadis Lykke Midtb øll Ørnbjerg Brigitte Michelsen Tore K Kvien Daniela Di Giuseppe Johan K Wallman Jakub Z ávada Sella A Provan Eirik Klami Kristianslund Ana Maria Rodrigues Maria Jos é Santos Žiga Rotar Katja Perdan Pirkmajer Dan Nord Source Type: research

Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
CONCLUSION: The 5-year benefit-risk profile for upadacitinib in RA remains favorable.PMID:38621793 | DOI:10.3899/jrheum.2023-1062 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Gerd R Burmester Filip Van den Bosch John Tesser Anna Shmagel Yanxi Liu Nasser Khan Heidi S Camp Alan Kivitz Source Type: research

Patient-Initiated Follow-Up
J Rheumatol. 2024 Apr 15:jrheum.2024-0302. doi: 10.3899/jrheum.2024-0302. Online ahead of print.ABSTRACTIn the contemporary healthcare climate, we are acutely aware that our resources are finite. This is particularly pertinent in government-funded healthcare settings, where clinical teams often face the challenge of meeting increasing patient demand with static or dwindling capacity.1-4.PMID:38621794 | DOI:10.3899/jrheum.2024-0302 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Edward Alveyn James Galloway Laura C Coates Source Type: research

Fibromyalgia and the Difficult Synthesis
J Rheumatol. 2024 Apr 15:jrheum.2024-0321. doi: 10.3899/jrheum.2024-0321. Online ahead of print.ABSTRACTThe pathophysiological uncertainties in fibromyalgia (FM) mean that its diagnosis, to this day, remains a strictly clinical exercise. The physician's evaluation of symptoms is therefore of fundamental importance both for the correct diagnostic framing of the patient and also for guiding a personalized therapeutic approach.1.PMID:38621795 | DOI:10.3899/jrheum.2024-0321 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Marco Di Carlo Benedetta Bianchi Fausto Salaffi Source Type: research

Knowledge of and stated adherence to the 2020 ACR Guideline for Gout Management: Results of a survey of US rheumatologists
CONCLUSION: The self-reported practice of the surveyed US rheumatologists was generally concordant with the 2020 ACR Guideline for the Management of Gout. However, there were gaps in guideline knowledge and stated adherence among rheumatologists, mainly concerning the dosing of treatment regimens.PMID:38621796 | DOI:10.3899/jrheum.2023-0981 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Naomi Schlesinger Michael H Pillinger Peter E Lipsky Source Type: research

When Should I Get My Next COVID Vaccine? Data from the SUrveillance of responses to COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)study
CONCLUSION: Ours is the first pan-Canadian IMID assessment of how vaccine history and other factors affect serologic COVID-19 vaccine responses. These findings may help individuals personalize vaccination decisions, including consideration of additional vaccination when >6 months has elapsed since last COVID vaccination/infection.PMID:38621797 | DOI:10.3899/jrheum.2023-1214 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Dawn M E Bowdish Vinod Chandran Carol A Hitchon Gilaad G Kaplan J Antonio Avina-Zubieta Paul R Fortin Maggie J Larch é Gilles Boire Anne-Claude Gingras Roya M Dayam Ines Colmegna Luck Lukusa Jennifer L F Lee Dawn P Richards Daniel Pereira Tania H Watts M Source Type: research

Feasibility of physiotherapist-led rheumatology triage: A randomized study
CONCLUSION: Physiotherapist-led triage was feasible, appeared as reliable as rheumatologist triage of referrals for joint pain, and lead to significantly fewer patients requiring in-clinic visits.PMID:38621798 | DOI:10.3899/jrheum.2023-1071 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Janet H Roberts Cheri Gun Jennifer E Mackinnon Susan Parlee Volodko Bakowsky Trudy Taylor Claire E H Barber John G Hanly Source Type: research

High Frequency of Diffuse Idiopathic Skeletal Hyperostosis in Patients With Obesity Hypoventilation Syndrome
J Rheumatol. 2024 Apr 15:jrheum.2024-0081. doi: 10.3899/jrheum.2024-0081. Online ahead of print.ABSTRACTDiffuse idiopathic skeletal hyperostosis (DISH) is known to be associated with metabolic syndrome and with obesity in particular. The prevalence of DISH increases with age, with an average of 10% in those aged 70 years and older.PMID:38621799 | DOI:10.3899/jrheum.2024-0081 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Shay Brikman Reuven Mader Amir Bieber Source Type: research

ASDAS-CRP and ASDAS-ESR cut-offs for disease activity states in axial spondyloarthritis - Are they interchangeable?
CONCLUSION: We estimated the optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-off values. However, applying the estimated cut-offs did not increase the level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states to a relevant degree. Our findings did not provide evidence to reject the established cut-off values for ASDAS-ESR.PMID:38621792 | DOI:10.3899/jrheum.2023-1217 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Stylianos Georgiadis Lykke Midtb øll Ørnbjerg Brigitte Michelsen Tore K Kvien Daniela Di Giuseppe Johan K Wallman Jakub Z ávada Sella A Provan Eirik Klami Kristianslund Ana Maria Rodrigues Maria Jos é Santos Žiga Rotar Katja Perdan Pirkmajer Dan Nord Source Type: research

Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
CONCLUSION: The 5-year benefit-risk profile for upadacitinib in RA remains favorable.PMID:38621793 | DOI:10.3899/jrheum.2023-1062 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Gerd R Burmester Filip Van den Bosch John Tesser Anna Shmagel Yanxi Liu Nasser Khan Heidi S Camp Alan Kivitz Source Type: research

Patient-Initiated Follow-Up
J Rheumatol. 2024 Apr 15:jrheum.2024-0302. doi: 10.3899/jrheum.2024-0302. Online ahead of print.ABSTRACTIn the contemporary healthcare climate, we are acutely aware that our resources are finite. This is particularly pertinent in government-funded healthcare settings, where clinical teams often face the challenge of meeting increasing patient demand with static or dwindling capacity.1-4.PMID:38621794 | DOI:10.3899/jrheum.2024-0302 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Edward Alveyn James Galloway Laura C Coates Source Type: research

Fibromyalgia and the Difficult Synthesis
J Rheumatol. 2024 Apr 15:jrheum.2024-0321. doi: 10.3899/jrheum.2024-0321. Online ahead of print.ABSTRACTThe pathophysiological uncertainties in fibromyalgia (FM) mean that its diagnosis, to this day, remains a strictly clinical exercise. The physician's evaluation of symptoms is therefore of fundamental importance both for the correct diagnostic framing of the patient and also for guiding a personalized therapeutic approach.1.PMID:38621795 | DOI:10.3899/jrheum.2024-0321 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Marco Di Carlo Benedetta Bianchi Fausto Salaffi Source Type: research

Knowledge of and stated adherence to the 2020 ACR Guideline for Gout Management: Results of a survey of US rheumatologists
CONCLUSION: The self-reported practice of the surveyed US rheumatologists was generally concordant with the 2020 ACR Guideline for the Management of Gout. However, there were gaps in guideline knowledge and stated adherence among rheumatologists, mainly concerning the dosing of treatment regimens.PMID:38621796 | DOI:10.3899/jrheum.2023-0981 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Naomi Schlesinger Michael H Pillinger Peter E Lipsky Source Type: research

When Should I Get My Next COVID Vaccine? Data from the SUrveillance of responses to COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)study
CONCLUSION: Ours is the first pan-Canadian IMID assessment of how vaccine history and other factors affect serologic COVID-19 vaccine responses. These findings may help individuals personalize vaccination decisions, including consideration of additional vaccination when >6 months has elapsed since last COVID vaccination/infection.PMID:38621797 | DOI:10.3899/jrheum.2023-1214 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Dawn M E Bowdish Vinod Chandran Carol A Hitchon Gilaad G Kaplan J Antonio Avina-Zubieta Paul R Fortin Maggie J Larch é Gilles Boire Anne-Claude Gingras Roya M Dayam Ines Colmegna Luck Lukusa Jennifer L F Lee Dawn P Richards Daniel Pereira Tania H Watts M Source Type: research

Feasibility of physiotherapist-led rheumatology triage: A randomized study
CONCLUSION: Physiotherapist-led triage was feasible, appeared as reliable as rheumatologist triage of referrals for joint pain, and lead to significantly fewer patients requiring in-clinic visits.PMID:38621798 | DOI:10.3899/jrheum.2023-1071 (Source: J Rheumatol)
Source: J Rheumatol - April 15, 2024 Category: Rheumatology Authors: Janet H Roberts Cheri Gun Jennifer E Mackinnon Susan Parlee Volodko Bakowsky Trudy Taylor Claire E H Barber John G Hanly Source Type: research